Venous Thromboembolism: A Preventable Postoperative Peril in Gynecologic Surgery
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT) and its potential sequel, pulmonary embolism (PE), poses a significant postoperative risk following extensive gynecologic procedures. Without prophylaxis, DVT develops in approximately 10-15% of patients, with nearly half of these cases progressing to PE. But here's where it gets controversial: while VTE is a leading cause of postoperative morbidity and mortality, it is also one of the most preventable complications when effective prophylactic strategies are implemented.
The Impact of VTE
A clot lodged in the deep venous system can block venous return, triggering acute symptoms such as dyspnoea, limb swelling, erythema, and calf tenderness. If left untreated, it may culminate in chronic post-thrombotic syndrome. PE, a secondary complication of postoperative DVT, is implicated in about 40% of unexpected deaths among women recovering from gynecologic surgery, generating substantial economic strain on healthcare systems.
Prophylactic Strategies: A Double-Edged Sword
Evidence demonstrates that targeted prophylaxis markedly lowers VTE frequency and severity at a favorable cost. Available strategies include systemic anticoagulants, such as standard or fractionated heparin regimens, and non-pharmacological measures like graduated compression hosiery and sequential pneumatic compression devices. And this is the part most people miss: while these methods are prized for their user-friendliness and minimal complications, they are not without risks. For instance, sequential compression is particularly valuable when anticoagulation is contraindicated, but it may not be suitable for all patients.
The Role of Surgical Techniques
Switching from open to endoscopic surgical techniques has been shown to diminish thromboembolic risk due to faster ambulation and shorter hospitalization. However, the perioperative application of mechanical thromboprophylaxis on coagulopathies, especially in gynecological benign patients undergoing minimal invasion surgery, lacks sufficient evidence of hematosis.
A Thought-Provoking Question
Given the limitations of current prophylactic strategies and the lack of comprehensive evidence, should we reconsider the standard approach to VTE prevention in gynecologic surgery? Could a more personalized, patient-specific strategy be the key to reducing VTE incidence and improving postoperative outcomes? These questions invite discussion and highlight the need for further research in this critical area of women's health.
